StockMarketWire.com - Advanced Oncotherapy has appointed Sanjeev Pandya as acting chief operating officer with immediate effect to replace Dr Sneh Khemka who has left to pursue his career elsewhere.

Pandya trained and practised as an orthopaedic surgeon in the NHS in the UK and in developing countries before working as a strategy consultant with McKinsey & Company.

He then spent two years at Pfizer Global Pharmaceuticals division before joining Lehman Brothers as an investment banker in healthcare M&A.

More recently, he has worked as an independent consultant in Russia and at Bupa in London. He has a medical degree from Trinity College, Cambridge and an MBA from INSEAD.

The company has also appointed Professor Christopher Nutting as a non-executive director with immediate effect.

Nutting will also join the company's medical advisory board, chaired by Dr Nick Plowman, senior clinical oncologist to St Bartholomew's Hospital and The Hospital for Sick Children Great Ormond Street, London.

Nutting replaces Professor Chris Boshoff who has resigned as a non-executive director in order to take up an appointment as vice-president for translational oncology at Pfizer, a position based in La Jolla, San Diego, California.


At 9:54am: [LON:AVO] share price was +0.03p at 3.25p



Story provided by StockMarketWire.com